| |
| |
|
| Insider
Information: |
Opaleye Management Inc. |
| Relationship: |
10% Owner |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
6 |
|
| Direct
Shares |
0 |
|
|
Indirect Shares
|
11,359,363 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$66,817,571 |
|
|
| Total
Shares |
11,359,363 |
|
|
| Total
Value |
$66,817,571 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
123
|
5
|
|
Stock
price went up :
|
64
|
3
|
| Stock
price went down : |
59
|
2
|
| |
|
|
|
Gain/Loss Ratio : |
1.1
|
1.5
|
| Percentage
Gain/Loss : |
 14.2%
|
 -54.2%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Harrow Health Inc |
HROW |
10% Owner |
2015-05-19 |
0 |
2024-04-25 |
3,815,000 |
Premium* |
|
|
Ocular Therapeutix, Inc |
OCUL |
10% Owner |
|
0 |
2020-01-02 |
4,918,500 |
Premium* |
|
|
Eton Pharmaceuticals, Inc. |
ETON |
10% Owner |
|
0 |
2021-11-17 |
2,375,000 |
Premium* |
|
|
Tracon Pharmaceuticals, Inc. |
TCON |
10% Owner |
2020-08-27 |
0 |
2023-11-10 |
0 |
Premium* |
|
|
Protara Therapeutics, Inc |
TARA |
10% Owner |
2020-09-24 |
0 |
2024-05-17 |
126,050 |
Premium* |
|
|
Tela Bio, Inc. |
TELA |
10% Owner |
2022-06-10 |
0 |
2022-11-03 |
124,813 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
158 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 7
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| TCON |
Tracon Pharmaceuticals, I... |
10% Owner |
– – • |
2020-09-23 |
4 |
B |
$4.83 |
$276,448 |
I/I |
57,200 |
1,764,438 |
1.5 |
% |
|
| TARA |
Protara Therapeutics, Inc |
10% Owner |
– – • |
2020-09-24 |
4 |
B |
$16.87 |
$5,061,000 |
I/I |
300,000 |
2,408,472 |
1.5 |
% |
|
| TCON |
Tracon Pharmaceuticals, I... |
10% Owner |
– – • |
2020-09-24 |
4 |
B |
$4.44 |
$95,648 |
I/I |
21,534 |
1,785,438 |
1.5 |
% |
|
| TARA |
Protara Therapeutics, Inc |
10% Owner |
– – • |
2020-09-30 |
4 |
B |
$16.00 |
$800,000 |
I/I |
50,000 |
2,458,472 |
1.5 |
% |
|
| ETON |
Eton Pharmaceuticals, Inc... |
10% Owner |
– – • |
2020-10-16 |
4 |
B |
$7.00 |
$2,800,000 |
I/I |
400,000 |
155,000 |
1.5 |
- |
|
| TCON |
Tracon Pharmaceuticals, I... |
10% Owner |
– – • |
2020-10-21 |
4 |
B |
$4.40 |
$38,060 |
I/I |
8,656 |
1,797,094 |
1.5 |
% |
|
| HROW |
Harrow Health Inc |
10% Owner |
– – • |
2020-12-18 |
4 |
B |
$5.31 |
$193,379 |
I/I |
36,400 |
133,300 |
1.5 |
% |
|
| HROW |
Harrow Health Inc |
10% Owner |
– – • |
2020-12-21 |
4 |
B |
$5.24 |
$280,093 |
I/I |
53,459 |
135,359 |
1.5 |
% |
|
| HROW |
Harrow Health Inc |
10% Owner |
– – • |
2020-12-22 |
4 |
B |
$5.19 |
$86,010 |
I/I |
16,557 |
136,016 |
1.5 |
% |
|
| TCON |
Tracon Pharmaceuticals, I... |
10% Owner |
– – • |
2020-12-22 |
4 |
B |
$8.06 |
$3,999,993 |
I/I |
496,277 |
2,293,371 |
1.5 |
% |
|
| HROW |
Harrow Health Inc |
10% Owner |
– – • |
2021-06-17 |
4 |
B |
$8.32 |
$93,701 |
I/I |
11,262 |
136,478 |
1.5 |
% |
|
| HROW |
Harrow Health Inc |
10% Owner |
– – • |
2021-06-18 |
4 |
B |
$8.35 |
$528,688 |
I/I |
63,322 |
140,000 |
1.5 |
% |
|
| HROW |
Harrow Health Inc |
10% Owner |
– – • |
2021-07-19 |
4 |
B |
$6.97 |
$40,897 |
I/I |
5,869 |
140,169 |
1.5 |
% |
|
| HROW |
Harrow Health Inc |
10% Owner |
– – • |
2021-07-20 |
4 |
B |
$7.20 |
$35,460 |
I/I |
4,925 |
140,294 |
1.5 |
% |
|
| HROW |
Harrow Health Inc |
10% Owner |
– – • |
2021-07-21 |
4 |
B |
$7.60 |
$69,933 |
I/I |
9,206 |
145,000 |
1.5 |
% |
|
| HROW |
Harrow Health Inc |
10% Owner |
– – • |
2021-08-17 |
4 |
B |
$8.57 |
$222,719 |
I/I |
26,000 |
146,000 |
1.5 |
% |
|
| HROW |
Harrow Health Inc |
10% Owner |
– – • |
2021-08-18 |
4 |
B |
$8.64 |
$401,979 |
I/I |
46,500 |
147,500 |
1.5 |
% |
|
| HROW |
Harrow Health Inc |
10% Owner |
– – • |
2021-08-19 |
4 |
B |
$8.45 |
$443,363 |
I/I |
52,500 |
150,000 |
1.5 |
% |
|
| TARA |
Protara Therapeutics, Inc |
10% Owner |
– – • |
2021-11-04 |
4 |
B |
$6.50 |
$42,621 |
I/I |
6,557 |
100,557 |
1.5 |
% |
|
| TARA |
Protara Therapeutics, Inc |
10% Owner |
– – • |
2021-11-17 |
4 |
B |
$6.98 |
$63,644 |
I/I |
9,118 |
101,647 |
1.5 |
% |
|
| TARA |
Protara Therapeutics, Inc |
10% Owner |
– – • |
2021-11-18 |
4 |
B |
$6.98 |
$106,130 |
I/I |
15,206 |
102,647 |
1.5 |
% |
|
| TCON |
Tracon Pharmaceuticals, I... |
10% Owner |
– – • |
2021-12-01 |
4 |
B |
$2.40 |
$120,160 |
I/I |
50,000 |
230,000 |
1.5 |
% |
|
| TCON |
Tracon Pharmaceuticals, I... |
10% Owner |
– – • |
2021-12-02 |
4 |
B |
$2.35 |
$24,660 |
I/I |
10,500 |
230,500 |
1.5 |
% |
|
| TCON |
Tracon Pharmaceuticals, I... |
10% Owner |
– – • |
2021-12-03 |
4 |
B |
$2.30 |
$204,911 |
I/I |
89,274 |
239,774 |
1.5 |
% |
|
| TCON |
Tracon Pharmaceuticals, I... |
10% Owner |
– – • |
2021-12-06 |
4 |
B |
$2.26 |
$51,474 |
I/I |
22,733 |
242,507 |
1.5 |
% |
|
158 Records found
|
|
Page 2 of 7 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
